**Abstract**

**Background:** Depot antipsychotics may significantly reduce relapse rates and enhance treatment continuation in patients with schizophrenia \[1,2\]. Paliperidone palmitate (PP) is a second generation long-acting antipsychotic that has been shown to be effective and well tolerated in clinical trials. Nevertheless, there is a need for real world data on clinical and economic outcomes \[3\]. The main purpose of this study is to establish the effects of PP on treatment continuation and hospital stay in routine clinical practice.

**Methods:** This is a naturalistic, mirror-image study of patients that have been initiated on PP between 2011 and 2015 in a large London mental healthcare trust. We examined patient demographics, retention rates and reasons for PP initiation and discontinuation as recorded in the medical notes. Furthermore, we evaluated the effect on the average number and length of admissions at year 1 and 2 in the pre and post PP periods.

**Results:** 198 consecutive patients were included in the study. 158 patients (80%) completed at least 1 year of treatment. The average number of admissions reduced from 0.7 the year before to 0.3 the year following PP initiation and the average number of bed days fell from 35 to 13 days respectively (p\<0.05). 118 patients (60%) completed at least 2 years of treatment. Mean number of admissions reduced from 0.7 pre PP to 0.3 in 1st year and 0.2 in 2nd year post PP and the mean bed days reduced from 34 days pre PP to 11 in 1st year and 15 days in 2nd year of treatment (p\<0.05). The main reasons for discontinuation were poor tolerability and non compliance.

**Conclusions:** The introduction of PP had a significant impact on the long term clinical outcomes in terms of reduced hospitalizations and high continuation rates in this naturalistic cohort.
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